Optimizing Formulations Data Improves Drug Development Kumar Jeetendra | October 2, 2024 hen it comes to drug development, optimizing formulations data is a critical step to streamlining the development process, leading to better therapeutic outcomes, reduced costs, and shorter time to market. The benefits of formulation optimization Formulation data is the intricate information concerning the composition and processes of producing a drug including active pharmaceutical ingredients (API), …
How to Choose the Right Fetal Bovine Serum for Your Experiments Kumar Jeetendra | February 18, 2025 Fetal Bovine Serum (FBS) is fundamental components for any cell culture and is used in nearly all biomedical science, including drug development and biotechnology. FBS contains a lot of nutrients, so it nourishes cells and helps with their growth and maintenance. FBS have to be chosen properly to guarantee that the experiments succeed. This is …
Revolutionizing Infectious Disease: Dr. Paul’s Journey Kumar Jeetendra | May 12, 2025 In this captivating episode of our podcast series, we feature the world-renowned microbiologist, inventor, and thought leader in anti-infectives and infectious disease R&D, Dr. Maneesh Paul. Key Highlights: The story of Enmetazobactam – India’s first indigenously developed anti-infective and its journey from concept to global approvals (DCGI, USFDA, UKMHRA, EMA). Aspects of AMR, Planetary Health, …
Alembic Pharma Gets EIR for API-I & II Facility at Panelav Kumar Jeetendra | September 15, 2025 Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) for the inspection conducted by the US Food and Drug Administration (USFDA) at its API-I and API-II facilities in Panelav. The inspection was carried out between May 26, 2025 and May 31, 2025. About Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited, a vertically integrated research and …
From Bench to Breakthrough Modernizing Analytical Testing in Pharma Kumar Jeetendra | October 9, 2025 Analytical testing remains foundational to pharmaceutical innovation, guaranteeing the safety, efficacy, and dependability of every pill, vial, and biologic sent to patients. Yet the industry’s increasing focus on complex biologics, personalized medicine, and accelerated development cycles suggests the need for innovative approaches to analysis. The industry must embrace innovation for modernization, including advanced technologies, automation, …
